Recombinant C5 (Ravulizumab Biosimilar) antibody

Catalog No. ABIN7597938

This Humanized Chimeric antibody specifically detects C5 (Ravulizumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant C5 (Ravulizumab Biosimilar) antibody (ABIN7597938)

Target: C5 (Ravulizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-C5 (Ravulizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Ravulizumab Biosimilar Antibody

Specificity: CPAMD4, C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG Mix kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for C5 (Ravulizumab Biosimilar)

Target: C5 (Ravulizumab Biosimilar)

Alternative Name: Ravulizumab Biosimilar

Target Type: Biosimilar

Background: CPAMD4, C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5

UniProt: P01031

CAS-No: 1803171-55-2